Neoadjuvant ultrahypofractionated radiotherapy with simultaneous integrated boost for glioblastoma: study protocol for a phase I multicenter clinical trial.
A novel radiation strategy before glioblastoma surgery aims to activate the immune system to fight remaining tumor cells more effectively.
This multicenter phase I trial protocol tests neoadjuvant ultrahypofractionated stereotactic radiotherapy with simultaneous integrated boost for glioblastoma. The novel approach aims to enhance anti-tumor immune response before surgery, though results are pending.
What the study was
- Study design
- Phase I clinical trial protocol
- Population
- Glioblastoma patients
- Category
- Treatment Innovation
- Maturity
- Exploratory
- Journal
- BMC cancer
Why it surfaced
Novel trial protocol for neoadjuvant SRT in GBM but no results yet. Protocol-only limits scoring.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.